381 related articles for article (PubMed ID: 26298296)
1. [Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer].
Villena R; Zubieta M; Hurtado C; Salgado C; Silva G; Fernández J; Villarroel M; Fernández M; Brahm J; O'Ryan M; Santolaya ME
Rev Chil Pediatr; 2015; 86(4):236-43. PubMed ID: 26298296
[TBL] [Abstract][Full Text] [Related]
2. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
3. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
4. The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study.
Wu Z; Yao J; Bao H; Chen Y; Lu S; Li J; Yang L; Jiang Z; Ren J; Xu KJ; Ruan B; Yang SG; Xie TS; Li Q
Hum Vaccin Immunother; 2018 May; 14(5):1251-1256. PubMed ID: 29337651
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U; Sethakarun S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
[TBL] [Abstract][Full Text] [Related]
6. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
[TBL] [Abstract][Full Text] [Related]
7. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
[TBL] [Abstract][Full Text] [Related]
8. [The immunogenicity of the Heberbiovac-HB vaccine in children].
Díaz González M; Chiang Macía A; Díaz Acosta D; Bravo González JR; Rodríguez Lay L; Pedroso Flaquet P; López-Chávez AU
Rev Cubana Med Trop; 1996; 48(3):195-8. PubMed ID: 9805051
[TBL] [Abstract][Full Text] [Related]
9. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
11. Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.
Da Villa G; Pelliccia MG; Peluso F; Ricciardi E; Sepe A
Res Virol; 1997; 148(2):109-14. PubMed ID: 9108609
[TBL] [Abstract][Full Text] [Related]
12. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
[TBL] [Abstract][Full Text] [Related]
13. Immune response of immunocompromised children with malignancies to a recombinant hepatitis B vaccine.
Polychronopoulou-Androulakaki S; Panagiotou JP; Kostaridou S; Kyratzopoulou A; Haidas S
Pediatr Hematol Oncol; 1996; 13(5):425-31. PubMed ID: 10897814
[TBL] [Abstract][Full Text] [Related]
14. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
15. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
17. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
18. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination in children with cancer.
Berberoğlu S; Büyükpamukcu M; Sarialioglu F; Akyüz C; Ilhan I
Pediatr Hematol Oncol; 1995; 12(2):171-8. PubMed ID: 7626386
[TBL] [Abstract][Full Text] [Related]
20. Response to hepatitis A and B vaccination in patients with chronic hepatitis C: 8-year follow-up.
Kalyoncu D; Urganci N
Paediatr Int Child Health; 2012 Aug; 32(3):136-9. PubMed ID: 22824660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
